Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06266429 · ClinicalTrials.gov registry record

Metabolomic Profiling of Racial Disparity

A clinical trial of Surgery and Tonsillar Hypertrophy, sponsored by Nationwide Children's Hospital.

Active
Registry status
84
Enrollment target
1
Study location

NCT06266429 is a study of Surgery and Tonsillar Hypertrophy that is active but no longer recruiting, run by Nationwide Children's Hospital. The registered enrollment target is 84 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06266429, a study of Surgery and Tonsillar Hypertrophy, is active but no longer recruiting, sponsored by Nationwide Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
84 participants
Enrollment target
1
Study location

Study Summary

Tonsillectomy ± adenoidectomy (T\&A) is one of the most common surgical operations with over 500,000 pediatric T\&As performed annually in the United States. Unfortunately, despite advances in anesthetic and surgical techniques, moderate-severe post-tonsillectomy pain (PTP) remains a significant problem affecting up to 62% of children. PTP is thought to arise from pharyngeal mucosal inflammation, which produces local nerve irritation and pharyngeal muscle spasm. Patient factors and surgical techniques also play major roles. Race is an important phenotypic risk factor for moderately severe early PTP. The underlying molecular basis of this differential pain experience is presently unknown. This gap in knowledge means that therapies are poorly targeted and often unsuccessful. Indeed, treatment options for PTP have not advanced substantively for many years. Metabolomics provides novel opportunities to investigate common and unique "metabolic signature" of PTP through the analysis of low molecular weight compounds produced in response to tissue injury. Therefore, the central themes of this proposal are that (1) PTP is a complex process that may be determined by molecular level factors such as preoperative systemic inflammation and metabolic profile, and (2) these molecular level factors may explain the excess burden of PTP among minority children. Here the investigators seek to utilize a combined clinical, biological and untargeted metabolomics approach to identify candidate small and large serum molecules that may influence the frequency and severity of PTP in children across racial groups. This approach to exploring the molecular basis of PTP is novel and knowledge from the study should substantially enhance understanding of the mechanisms underlying pediatric PTP - and narrow the racial disparities in post-operative pain.

Interventions

  • DIAGNOSTIC_TEST Blood collection

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 84 participants
Start Date 2024-03-12
Est. Completion 2026-12-31

Sponsor

Nationwide Children's Hospital

188 total trials

What the Registry Record Tells You About NCT06266429

The ClinicalTrials.gov registry entry for NCT06266429 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Surgery appearing as the primary indexed condition, and to 1 intervention - of which Blood collection is the first listed.

NCT06266429 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06266429 about?

NCT06266429 is a clinical study titled "Metabolomic Profiling of Racial Disparity". Tonsillectomy ± adenoidectomy (T\&A) is one of the most common surgical operations with over 500,000 pediatric T\&As performed annually in the United States. Unfortunately, despite advances in anesthetic and surgical techniques, moderate-severe post-tonsillectomy pain (PTP) remains a significant pro...

What is the current status of trial NCT06266429?

This trial is currently active not recruiting. The enrollment target is 84 participants. The study started on 2024-03-12. Estimated completion is 2026-12-31.

What conditions does trial NCT06266429 study?

This clinical trial studies the following conditions: Surgery, Tonsillar Hypertrophy, Adenoid Hypertrophy.

What interventions are being tested in trial NCT06266429?

The interventions under investigation include: Blood collection (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT06266429?

This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06266429 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.